map of California title=California
California Medicaid 1915(c) HCBS Waivers, 2007.

In 2007, there were 84,249 participants in the 6 waiver programs in California (Table 1) with expenditures totaling $1,675,560,117 (an average expenditure per capita of $46.06) (Table 2).



Table 1. California 1915(c) HCBS Waiver Participants, by Waiver and Waiver Target Group, 2007
Waiver Name
by Waiver Target Group 		 Number of California 
Participants		  California Participants per 1,000 
Population		  US Participants per 1,000 
Population
 Total MR/DDnote66,0091.811.56
      DD 66,0091.81—
 Total Aged/Disabled14,2130.391.49
      MSSP 14,0080.39—
      Assisted Living 2050.01—
 Total Disabled/Physically Disabled1,2830.040.23
      Nursing Facility A/B 1,0950.03—
      In Home Operations 1880.01—
 Total HIV/AIDSnote2,7450.080.04
      AIDS 2,7450.08—
 Total84,249——
Table 2. California 1915(c) HCBS Waiver Expenditures, by Waiver and Waiver Target Group, 2007
Waiver Name
by Waiver Target Group		  California Expenditures    Expenditures per Capita   US Expenditures per Capita 
 Total MR/DDnote$1,550,657,711$42.63$65.58
      DD $1,550,657,711$42.63—
 Total Aged/Disabled$49,745,534$1.37$14.64
      MSSP $48,388,879$1.33—
      Assisted Living $1,356,655$0.04—
 Total Disabled/Physically Disabled$64,767,475$1.78$3.81
      Nursing Facility A/B $48,611,653$1.34—
      In Home Operations $16,155,822$0.44—
 Total HIV/AIDSnote$10,389,397$0.29$0.15
      AIDS $10,389,397$0.29—
 Total$1,675,560,117——

This information is part of the Center for PAS report:

Ng, T. & Harrington, C. (August 2011). Medicaid Home and Community-Based Services Data, 2007.

Source: Center for PAS analysis of CMS Form 372 waiver data.

Notes:

Total MR/DD: Mental Retardation/Developmentally Disabled

Total HIV/AIDS: Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome


To see California's waiver data for a previous year, please select a link below:

Choose Another State


Select from Map or Button: Map of the 50 US states. Choose another state for page.